Korro Bio, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Korro Bio, Inc. on November 14, 2023, covering events occurring on November 8 and November 10, 2023. The filing discloses the execution of new employment agreements with the company's President and Chief Executive Officer, Ram Aiyar, Ph.D., and its Treasurer and Chief Financial Officer, Vineet Agarwal.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements.
Material Changes and Executive Compensation
The primary material change is the formalization of employment terms for two key executives, providing enhanced severance protections in the event of termination without cause, resignation for good reason, or a change in control.
- Ram Aiyar, Ph.D. (CEO):
- Base Salary: $498,487 annually.
- Target Bonus: 45% of base salary.
- Standard Severance (Outside Change in Control): 12 months base salary, pro rata bonus, and up to 12 months COBRA coverage.
- Change in Control Severance: 18 months base salary, 1.5x target bonus, up to 18 months COBRA, and accelerated vesting of time-based and certain performance-based equity.
- Vineet Agarwal (CFO):
- Base Salary: $426,483 annually.
- Target Bonus: 35% of base salary.
- Standard Severance (Outside Change in Control): 9 months base salary, pro rata bonus, and up to 9 months COBRA coverage.
- Change in Control Severance: 12 months base salary, 1.0x target bonus, up to 12 months COBRA, and accelerated vesting of time-based equity.
Outlook, Risks, and Contingencies
The filing notes that payments made in connection with a change in control may be subject to the "golden parachute" rules under Sections 280G and 4999 of the Internal Revenue Code. This could result in the company losing federal income tax deductions and the executives being subject to an excise tax. The agreements include a "netting" provision to reduce payments if doing so results in a higher net after-tax benefit to the executive.
Investor Verification Checklist
- Review the full text of the employment agreements filed as Exhibit 10.1 (CEO) and Exhibit 10.2 (CFO) for complete definitions of "cause," "good reason," and "change in control."
- Verify the total potential cash and equity payout obligations in a change in control scenario against the company's current cash position.
- Confirm the status of any prior offer letters referenced in the filing to ensure no conflicting terms exist.
- Assess the impact of potential Section 280G tax deductions on the company's future effective tax rate.